S&P 500   4,567.18
DOW   36,124.56
QQQ   387.29
Investing in quantum computing: A guide 
U.S. Military Defense Fails Without Vanadium? (Ad)
What is dividend harvesting?
Marvell Technology at a critical pivot: 30% upside is possible
Countries Are Investing Heavily Into Securing Energy Independence (Ad)
What analysts wanted out of Chewy stock is finally here
Even Scrooge can’t pass up these 3 bargain stocks
Countries Are Investing Heavily Into Securing Energy Independence (Ad)
The truth about DocuSign's relevancy in today's world: Surprise
SoFi expands ETF business with options-driven income fund
S&P 500   4,567.18
DOW   36,124.56
QQQ   387.29
Investing in quantum computing: A guide 
U.S. Military Defense Fails Without Vanadium? (Ad)
What is dividend harvesting?
Marvell Technology at a critical pivot: 30% upside is possible
Countries Are Investing Heavily Into Securing Energy Independence (Ad)
What analysts wanted out of Chewy stock is finally here
Even Scrooge can’t pass up these 3 bargain stocks
Countries Are Investing Heavily Into Securing Energy Independence (Ad)
The truth about DocuSign's relevancy in today's world: Surprise
SoFi expands ETF business with options-driven income fund
S&P 500   4,567.18
DOW   36,124.56
QQQ   387.29
Investing in quantum computing: A guide 
U.S. Military Defense Fails Without Vanadium? (Ad)
What is dividend harvesting?
Marvell Technology at a critical pivot: 30% upside is possible
Countries Are Investing Heavily Into Securing Energy Independence (Ad)
What analysts wanted out of Chewy stock is finally here
Even Scrooge can’t pass up these 3 bargain stocks
Countries Are Investing Heavily Into Securing Energy Independence (Ad)
The truth about DocuSign's relevancy in today's world: Surprise
SoFi expands ETF business with options-driven income fund
S&P 500   4,567.18
DOW   36,124.56
QQQ   387.29
Investing in quantum computing: A guide 
U.S. Military Defense Fails Without Vanadium? (Ad)
What is dividend harvesting?
Marvell Technology at a critical pivot: 30% upside is possible
Countries Are Investing Heavily Into Securing Energy Independence (Ad)
What analysts wanted out of Chewy stock is finally here
Even Scrooge can’t pass up these 3 bargain stocks
Countries Are Investing Heavily Into Securing Energy Independence (Ad)
The truth about DocuSign's relevancy in today's world: Surprise
SoFi expands ETF business with options-driven income fund

Guardion Health Sciences Stock Price, News & Analysis (NASDAQ:GHSI)

$5.97
-0.01 (-0.17%)
(As of 12/5/2023 ET)
Compare
Today's Range
$5.95
$6.20
50-Day Range
$5.23
$7.64
52-Week Range
$4.66
$10.49
Volume
7,427 shs
Average Volume
13,200 shs
Market Capitalization
$7.64 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

GHSI stock logo

About Guardion Health Sciences Stock (NASDAQ:GHSI)

Guardion Health Sciences, Inc., a clinical nutrition company, develops and distributes clinically supported nutrition, medical foods, and dietary supplements in North America and Europe, and Internationally. The company offers Lumega-Z, a medical food that replenishes and restores the macular protective pigment; and GlaucoCetin, a vision-specific medical food to support and protect the mitochondrial function of optic nerve cells, as well as improve blood flow in the ophthalmic artery in patients with glaucoma. It develops ImmuneSF, a nutraceutical formulation, as well as a portfolio of nutraceutical products under the NutriGuard brand. Further, it distributes medical foods products through e-commerce in an online store, guardionhealth.com. Guardion Health Sciences, Inc. was founded in 2009 and is headquartered in Houston, California.

GHSI Stock Price History

GHSI Stock News Headlines

Guardion Health Sciences (NASDAQ:GHSI) Trading Down 0.2%
All the trading advice you’ve ever received boils down to this
All the trading advice you’ve ever received boils down to one goal and one goal only: finding a reliable edge in the markets. If you can do that, grab hold of it and never let go. Because once you have that edge, and you can count on it, you never need to do anything else.
GHSI - Guardion Health Sciences, Inc.
All the trading advice you’ve ever received boils down to this
All the trading advice you’ve ever received boils down to one goal and one goal only: finding a reliable edge in the markets. If you can do that, grab hold of it and never let go. Because once you have that edge, and you can count on it, you never need to do anything else.
GHSI Guardion Health Sciences, Inc.
See More Headlines
Receive GHSI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Guardion Health Sciences and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/13/2023
Today
12/05/2023
Fiscal Year End
12/31/2023
Next Earnings (Estimated)
4/15/2024

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:GHSI
Employees
12
Year Founded
2009

Profitability

Net Income
$-14,920,000.00
Net Margins
-105.66%
Pretax Margin
-105.66%

Debt

Sales & Book Value

Annual Sales
$11.05 million
Cash Flow
$5.28 per share
Book Value
$6.43 per share

Miscellaneous

Free Float
1,258,000
Market Cap
$7.64 million
Optionable
Not Optionable
Beta
0.88

Social Links

The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Key Executives

  • Mr. Robert Neal Weingarten (Age 71)
    Independent Chairman & Secretary
    Comp: $79k
  • Mr. Craig J. Sheehan (Age 52)
    Chief Commercial Officer
    Comp: $256.88k
  • Ms. Janet Hall (Age 64)
    President & CEO
  • Ms. Katie Cox (Age 53)
    Chief Accounting Officer














GHSI Stock Analysis - Frequently Asked Questions

How have GHSI shares performed in 2023?

Guardion Health Sciences' stock was trading at $7.2550 at the beginning of the year. Since then, GHSI shares have decreased by 17.7% and is now trading at $5.97.
View the best growth stocks for 2023 here
.

When is Guardion Health Sciences' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, April 15th 2024.
View our GHSI earnings forecast
.

How were Guardion Health Sciences' earnings last quarter?

Guardion Health Sciences, Inc. (NASDAQ:GHSI) announced its earnings results on Monday, November, 13th. The company reported $0.29 earnings per share for the quarter. The firm earned $3.34 million during the quarter. Guardion Health Sciences had a negative trailing twelve-month return on equity of 162.33% and a negative net margin of 105.66%.

When did Guardion Health Sciences' stock split?

Guardion Health Sciences shares reverse split on Sunday, January 8th 2023. The 1-50 reverse split was announced on Sunday, January 8th 2023. The number of shares owned by shareholders was adjusted after the market closes on Sunday, January 8th 2023. An investor that had 100 shares of stock prior to the reverse split would have 2 shares after the split.

What other stocks do shareholders of Guardion Health Sciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Guardion Health Sciences investors own include Biocept (BIOC), Onconova Therapeutics (ONTX), Heat Biologics (HTBX), VBI Vaccines (VBIV), Inovio Pharmaceuticals (INO), Ocugen (OCGN), Tonix Pharmaceuticals (TNXP), Co-Diagnostics (CODX) and FuelCell Energy (FCEL).

When did Guardion Health Sciences IPO?

(GHSI) raised $6 million in an initial public offering on Friday, April 5th 2019. The company issued 1,500,000 shares at $4.00 per share. WallachBeth Capital and Westpark Capital served as the underwriters for the IPO.

How do I buy shares of Guardion Health Sciences?

Shares of GHSI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NASDAQ:GHSI) was last updated on 12/6/2023 by MarketBeat.com Staff

My Account -